NCT06765265

Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome

• Status: Recruiting
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 152 (estimated)
• Sponsor: King Edward Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

there will be 2 groups of patients with acute coronary syndrome. The patients will receive one of the 2 study drugs and impact on raising Vitamin D level will be seen after 6 months

Detailed description

this randomized clinical trial will include 152 patients of acute coronary syndrome with normal Vitamin D levels. they will be randomized to receive either Atorvastatin or Rosuvastatin. After 6 months of therapy, the impact on Vitamin D levels will be checked

Conditions

• Acute Coronary Syndromes

Interventions

Type	Name	Description
DRUG	Rosuvastatin 20 mg/day	Rosuvastatin 20 mg / Day for 24 weeks
DRUG	Atorvastatin 40 mg	Atorvastatin 40mg / Day for 24 weeks

Timeline

• Start date: 2025-01-05
• Primary completion: 2026-01-01
• Completion: 2026-01-01
• First posted: 2025-01-09
• Last updated: 2025-03-11

Locations

1 site across 1 country: Pakistan